Buyer guide
How Much Does Bioinformatics Analysis Cost? A Transparent Guide
What drives bioinformatics analysis cost and how to scope a quote by modality, sample count, and deliverable depth.
Buyer guide
What drives bioinformatics analysis cost and how to scope a quote by modality, sample count, and deliverable depth.
Published academic-core rate cards anchor most budget conversations; commercial CROs and in-house teams scope to the same drivers but rarely publish flat fees.
| Category | Details | Source |
|---|---|---|
| Bulk RNA-seq analysis (standard pipeline, 6–15 samples) | $1,000–$2,500 per project | [1] |
| scRNA-seq analysis (6–25 samples) | $2,000–$4,000 per project | [1] |
| Multi-omics integration (~6 samples) | $5,000–$6,000 over 3–6 months | [2] |
| US bioinformatics scientist median base salary | ~$106,000 (range $70k–$147k) | [3] |
| Sequencing vs. analysis billing | Analysis almost always priced separately from library prep and sequencing | [2] |
| Grant-budgetable data management costs | Allowable as justified direct costs under NIH, UKRI, and Wellcome policies | [4] |
| Identical results on automated notebook reruns | 5.6% of Python notebooks with declared dependencies (879 of 15,817) | [5] |
Cost scales with sample count, analysis depth, data modality, turnaround pressure, deliverable type, and data quality, not a single per-sample rate. Two projects with the same sample number can differ substantially if one needs a standard differential-expression report and the other needs custom integration, publication figures, and containerized workflows.
| Factor | How it affects price |
|---|---|
| Sample count | Near-linear for QC, mapping, and differential testing across conditions |
| Analysis depth | Standard pipeline vs. custom methods, pathway modelling, or algorithm development |
| Data modality | Bulk RNA-seq (mature tooling) vs. spatial, long-read, or multi-omics integration |
| Turnaround | Rush timelines typically increase cost; extent varies by provider |
| Deliverable type | HTML report vs. publication-grade figures, Methods draft, and versioned code |
| Data quality issues | Failed QC, batch effects, or re-sequencing add unplanned analyst hours |
Schurch et al. [6] found that under-powered RNA-seq designs waste sequencing spend: with only three biological replicates per condition, most differential-expression tools recovered just 20–40% of genes found with adequate replication. Getting the design right before budgeting analysis avoids wasted cost across both wet lab and compute.
Published academic-core rate cards provide the most transparent benchmarks; commercial CROs quote individually. Sequencing is almost always billed separately [2].
| Analysis type | Academic core / facility | Commercial CRO | In-house |
|---|---|---|---|
| Bulk RNA-seq (9–12 samples, standard DE) | ~$1,500–$2,000 [1, 2] | Quote-based | Coriell publishes 4–8 analyst hours for 6–12 samples [1] |
| scRNA-seq (clustering + DE) | ~$2,500–$4,000 [1]; ~$3,000 [2] | Quote-based | Higher analyst time; platform learning curve |
| ATAC-seq | ~$3,000 [2] | Quote-based | Infrastructure + analyst FTE |
| Multi-omics integration (~6 samples) | $5,000–$6,000 [2] | Quote-based | Multiple FTE-months |
| Study design / consulting | Hourly or day rate | Fixed memo | PI and analyst opportunity cost |
In-house is not free. A US bioinformatics scientist earns a median base salary of roughly $106,000 (range $70,000–$147,000) [3], plus benefits, F&A, compute, and opportunity cost. NIH grant budgets must respect the salary cap ($228,000 effective January 2026) [7]. Hiring works well for continuous high-volume analysis; for one-off projects, cores or outsourcing often cost less.
A standard outsourced quote typically covers raw-data QC, alignment or quantification, primary differential testing, a results report, and one review session. Coriell Institute's published tiers include a one-hour meeting with additional work billed hourly [1]. Pepkio scopes projects with milestone pricing, so you pay against agreed deliverables rather than an open hourly clock.
Milestone pricing ties payment to deliverable acceptance. Get the hourly overflow rate and change-order process in writing before any scope expansion.
The most costly mistake is treating "analysis included with sequencing" as publication-ready bioinformatics.
Pitt GAC recommends budgeting bioinformatics during experimental planning, not after sequencing starts [2].
A ~$2,000 analysis quote excludes the sequencing bill.
Schurch et al. [6] recommend ≥6 biological replicates per condition (≥12 for all fold changes).
NIH allows justified direct costs for curation and repository deposit [8]; UKRI BBSRC permits scoped FTE for data-analysis support [4].
Fixed or milestone pricing is more predictable for defined deliverables; hourly billing can overrun when scope is not fully specified upfront.
Piccolo & Frampton [9] document missing version metadata in NGS papers; Samuel & Mietchen [5] found only 5.6% of notebooks with declared dependencies reproduced identical results on rerun.
Send the same scope document to two or three providers and compare line items, not headline totals.
Sample count, replicates, comparisons.
Bulk/scRNA-seq, WGS; short- vs long-read.
Reference genome/build or custom reference needs.
Count matrices, objects, figures, Methods draft, code repo, containers.
Turnaround and rush requirements.
Milestones, deposit, hourly overflow rate.
Scope-change policy for added contrasts or batch redo.
Encrypted transfer, isolated compute, NDA, deletion timeline.
Reviewer support: included or billed separately.
Code ownership and publication licence.
An initial scoping consultation with an academic core or qualified provider is often free [1, 2, 10] and can prevent budget surprises after sequencing.
Published academic-core rates run roughly $1,000 for six samples to $2,500 for fifteen on standard bulk RNA-seq [1]. Pitt GAC quotes approximately $2,000 for a nine-sample, three-condition design, analysis only with sequencing billed separately [2]. Commercial CROs quote individually; standard pipelines often fall in similar ranges, but publication deliverables or rush timelines tend to cost more.
Single-cell analysis costs more than bulk because of cell-level QC, clustering, and marker testing. Coriell Institute publishes $2,000 for six samples up to $4,000 for twenty-five [1]. Pitt GAC estimates approximately $3,000 for Cell Ranger, Seurat, and marker analysis [2]. Batch integration, multiome data, or trajectory inference add scope beyond those baselines.
For a single project, outsourcing (roughly $2,000 for standard bulk RNA-seq at academic-core rates) is typically cheaper than a full-time hire (median base salary approximately $106,000 plus benefits and overhead; PayScale, 2026). Hiring makes sense when you need year-round pipeline development, continuous throughput, or deep institutional memory. Specialist one-offs—spatial, multi-omics, reviewer sprints—usually cost less outsourced. See Outsourcing vs. Hiring.
Every project differs in sample count, modality, data quality, and deliverables, so effort is hard to standardize. Academic cores publish tiered rate cards for standardized pipelines [1, 2]; commercial CROs prefer scoping calls to avoid misquotes on under-specified work. A transparent quote process matters more than a headline price on a website.
Published academic-core hourly rates include $70–$90/hr for internal users at UNMC BSBC [10] and $75/hr internal / $135/hr external at Fred Hutch [11]; external academic rates at UNMC are 1.5× internal subsidized rates. Commercial consultants may charge more. Compare hourly quotes against fixed fees for the same scope.
Usually not. Pitt GAC states that sequencing core costs are separate from bioinformatics analysis prices [2]. Sequencing vendors may include a basic automated QC report, but publication-ready analysis with biological interpretation, version-pinned code, and scientist review is typically a separate line item. Ask what "analysis included" covers before comparing quotes.
Yes. NIH allows justified direct costs for data management, curation, repository fees, and supporting personnel [8]. Analyst effort goes in personnel; repository and compute in appropriate direct-cost categories. UKRI BBSRC and Wellcome expect fully scoped, justified project costs including data-management support where needed [4, 12].
Plan for sequencing and library prep (separate bill), cloud/HPC if self-hosting, repository fees, added contrasts, batch-correction reruns, figure revisions, and post-publication code maintenance. Wellcome recommends asking for enough funding to complete the project as scoped [12]. A contingency buffer for QC surprises is worth including.
Worth questioning. Published academic tiers start at $1,000 for six samples on a standard bulk RNA-seq pipeline [1], so half that price is below any published academic benchmark we have seen. A $500 quote may cover only minimal automated QC, exclude differential testing, omit scientist review, or assume pre-processed data. Ask which pipeline steps are included and who reviews QC decisions before signing.
Fixed or milestone pricing works well for defined scope: known sample count, standard pipeline, agreed deliverables. Hourly billing suits consulting or evolving scope where effort cannot be estimated upfront. For defined RNA-seq or WGS projects, fixed pricing protects against overrun; for open-ended exploration, hourly with a not-to-exceed cap is reasonable for both sides. Pepkio uses milestone-based fixed pricing on scoped analysis projects, so you know the total before work starts.
Tell us:
We'll tell you:
Contact us to start with a free consultation. Need everyday bench calculators? Try our free lab tools.